Val­neva's Covid-19 vac­cine con­tract with Eu­rope col­laps­es to just a frac­tion of the orig­i­nal deal

The Eu­ro­pean Com­mis­sion on Wednes­day an­nounced that it would on­ly pur­chase 1.25 mil­lion dos­es of Val­ne­va’s new­ly au­tho­rized Covid-19 vac­cine, af­ter orig­i­nal­ly pur­chas­ing 60 mil­lion dos­es.

The EC first sent a no­tice of in­tent to ter­mi­nate the pur­chase agree­ment back in May, as the reg­u­la­to­ry re­view of Val­ne­va’s vac­cine stalled. In late June, the Eu­ro­pean Med­i­cines Agency rec­om­mend­ed Val­ne­va’s shot for the pri­ma­ry vac­ci­na­tion of adults, but the com­pa­ny warned that its sup­ply deal might be dead in the wa­ter.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER